Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
12/1991
12/04/1991EP0458903A1 Soluble analogs of thrombomodulin
12/04/1991EP0458901A1 Inhibiting transformation of cells having elevated purine metabolic enzyme activity
12/04/1991EP0308456B1 Compositon for the treatment of the epiderm
12/04/1991EP0073210B1 Caries inhibition
12/04/1991CN1056632A Apparatus preparing concentrate of coagulation factors, such as fibrinogen, from blood sample
12/03/1991US5070188 Acylated epidermal growth factor
12/03/1991US5070187 Pharmacologically effective antagonists of arginine-vasopressin
12/03/1991US5070074 Insulinase inhibitors
12/03/1991US5069896 Malodor inhibiting skin deodorant composition comprising a monoclonal antibody and method of deodorizing
12/03/1991CA1292841C Peptide derivatives, their production and use
12/03/1991CA1292708C Monoclonal antibody against plasminogen-activating factor
12/03/1991CA1292686C Pharmaceutical compositions of recombinant interleukin-2 and formulation process
12/03/1991CA1292685C ANTITUMOR AGENT CONTAINING INTERLEUKIN-2 AND INTERFERON-.alpha.
12/02/1991WO1991018866A2 1,4-diamino-2,3-dihydroxybutanes
12/02/1991CA2084087A1 1,4-diamino 2,3-dihydroxy butanes
12/02/1991CA2043620A1 Microbially expressed portions of a monoclonal antibody block rhinovirus attachment to cell receptors
12/02/1991CA2043603A1 Hiv protease inhibitors and processes for their preparation
12/01/1991WO1991018925A1 Novel megakaryocyte colony stimulating factor and production thereof
12/01/1991WO1991018919A1 Purification of human interleukin-4 from a secreted escherichia coli mutant
12/01/1991WO1991018639A1 Method for using fibronectin in conjunction with percutaneous transluminal coronary angioplasty
12/01/1991CA2084078A1 Method for using fibronectin in conjunction with percutaneous transluminal coronary angioplasty
12/01/1991CA2084074A1 Megakaryocyte colony stimulating factor and production thereof
12/01/1991CA2042159A1 Method for preventing onset of restenosis after angioplasty employing an ace inhibitor
12/01/1991CA2041951A1 Method for preventing onset of restenosis after angioplasty employing pravastatin
12/01/1991CA2018136A1 Preparation and employment of a physiologically active polypeptide for aids therapy
11/1991
11/30/1991CA2043049A1 Precursor forms of procine growth hormone releasing factor and related dna compounds
11/29/1991WO1991018990A1 Method of preparing plasmid having capabilities of expressing and processing after translation of retrovirus gene, plasmid obtained thereby and product of expression thereof
11/28/1991WO1991018293A1 Monoclonal antibodies specific for toxin b of clostridium difficile
11/28/1991WO1991018104A1 Indh enzyme compositions and their methods of use
11/28/1991WO1991018098A1 Bone and cartilage inductive proteins
11/28/1991WO1991018097A1 Cd46 variants
11/28/1991WO1991018088A1 Adeno-associated virus (aav)-based eucaryotic vectors
11/28/1991WO1991018018A1 Improved pseudomonas chimeric protein cytotoxic to human cells bearing il2 receptors
11/28/1991WO1991018016A1 Biologically active peptides containing d-2-alkyltryptophan
11/28/1991WO1991018015A1 Alveolar surfactant proteins
11/28/1991WO1991018013A1 Synthetic senescent cell antigen
11/28/1991WO1991018011A1 Inhibition of cell adhesion using intercellular adhesion molecule-1-like peptides and/or analogues thereof
11/28/1991WO1991018010A1 Inhibition of viral infection using intercellular adhesion molecule-1-like peptides and/or analogues thereof
11/28/1991WO1991018004A1 Antisense inhibitors of the human immunodeficiency virus
11/28/1991WO1991017778A1 An apparatus for preparing a concentrate of coagulation factors, such as fibrinogen, from a blood sample
11/28/1991WO1991017773A2 New protein-polycation conjugates
11/28/1991WO1991017770A1 Synergistic tumor therapy with combinations of biologically active anti-tumor antibodies and chemotherapy
11/28/1991WO1991017767A1 Method of treating inhibition of dipeptidyl aminopeptidase type iv
11/28/1991WO1991017766A1 Remedy for asthma
11/28/1991WO1991017765A1 Fibrin binding domain polypeptides and uses and methods of producing same
11/28/1991WO1991017763A1 PEPTIDE DERIVATIVES OF CYTOCHROME b558 AND THEIR USE AS MEDICAMENTS
11/28/1991WO1991017762A1 Selective retroviral proteinase inhibitor
11/28/1991WO1991017760A1 Composition of and treatment with biologically active peptides having d-amino acid residues
11/28/1991WO1991017759A1 Trypanosomal immunosuppressive factor
11/28/1991WO1991015204A3 Method and agents for the selective reduction of lp(a)
11/28/1991WO1991014437A3 Use of copper(ii) containing compounds to accelerate wound healing
11/28/1991WO1991005754A3 Derivatives of long-chain fatty alcohols and their applications, in particular as cytotrophic and cytoprotective molecules, and pharmaceutical compositions containing same
11/28/1991DE4016994A1 New anhydro-statin-phosphono:pyrrolidine(s) and -piperidine(s) - useful as antiviral cpds. in human and animal medicine, active against e.g. HIV
11/28/1991CA2083391A1 Synergistic tumor therapy with combinations of biologically active anti-tumor antibodies and chemotherapy
11/28/1991CA2083150A1 Synthetic senescent cell antigen
11/28/1991CA2082941A1 Bone and cartilage inductive proteins
11/28/1991CA2082631A1 Antisense inhibitors of the human immunodeficiency virus
11/28/1991CA2082277A1 Cd46 variants
11/28/1991CA2063709A1 Monoclonal antibodies specific for toxin b of clostridium difficile
11/27/1991EP0458644A1 A micro-organism and proteases therefrom
11/27/1991EP0458537A2 Therapeutic compound for the treatment of bronchitis
11/27/1991EP0458536A2 Therapeutic agent for treatment and prevention of adult respiratory distress syndrome
11/27/1991EP0458535A2 Therapeutic product for the treatment of cystic fibrosis
11/27/1991EP0458167A1 Fatty acid-pulmonary surfactant conjugates
11/27/1991EP0458072A1 Immunologic enhancement of the somatogenic effect of somatotropin with an antibody
11/27/1991EP0458064A2 Stabilization of somatotropins and other proteins by modification of cysteine residues
11/27/1991EP0457919A1 Functional food
11/27/1991EP0457875A1 Chimeric mouse-human a10 antibody with specificity to a human tumor cell antigen
11/27/1991EP0457837A1 Stabilization of aqueous-based hydrophobic protein solutions and sustained release vehicle
11/27/1991EP0457786A1 Stabilized, potent grf analogs
11/27/1991EP0349593B1 Method of producing high aqueous volume multilamellar vesicles
11/27/1991EP0201574B1 A preparation for the treatment of hemophilia a inhibitor patients and a process for producing such a preparation
11/27/1991CN1056427A Gene therapy for cell proliferative diseases
11/27/1991CA2043143A1 Retrovirally active new anhydrostatin phosphonopyrrolidines and piperidines
11/26/1991WO1991018921A1 GROWTH FACTOR WHICH INHIBITS THE GROWTH OF CELLS OVEREXPRESSING THE HUMAN ONCOGENE erbB-2
11/26/1991WO1991018618A2 Immunotherapeutic compositions for treating and preventing aids, arc and hiv infection
11/26/1991US5068354 Cathepsin B inhibitors, enzyme inhibitors for muscular disorders
11/26/1991US5068351 Catalytic amidation in the presence of phosphinic anhydride, cyclization
11/26/1991US5068317 Methionine derived human growth hormones
11/26/1991US5068315 Composition for the regulation of hair growth
11/26/1991US5068314 Lipopolysaccharide-binding polypeptide
11/26/1991US5068242 Pyrrolidine-2-carboxylic acid derivatives and their use for psychotropic action
11/26/1991US5068224 Method of improving regeneration of transfected peripheral nerves using igf-1
11/26/1991US5068223 Hydrophobic peptide esters and amides
11/26/1991US5068222 Polypeptides for treatment of cancer
11/26/1991US5068221 Gonadotropin Releasing Hormone, oligopeptides for gastrointestinal disorders
11/26/1991US5068109 Antacid composition
11/26/1991US5068106 Tissue plasminogen activator in protein solution
11/26/1991US5067961 Non-biodegradable two phase corneal implant and method for preparing same
11/26/1991CA2083688A1 Growth factor which inhibits the growth of cells overexpressing the human oncogene erbb-2
11/26/1991CA2062758A1 Immunotherapeutic compositions for treating and preventing aids, arc and hiv infection
11/25/1991CA2043132A1 Therapeutic product
11/25/1991CA2043107A1 Therapeutic compound
11/25/1991CA2043106A1 Therapeutic agent
11/24/1991WO1991018107A1 Measuring non-dystrophin proteins and diagnosing muscular dystrophy
11/24/1991CA2083598A1 Measuring non-dystrophin proteins and diagnosing muscular dystrophy
11/23/1991WO1991017769A1 Novel methods for producing antigen-specific, high-affinity human monoclonal antibodies
11/23/1991CA2082041A1 Methods for producing antigen-specific, high-affinity human monoclonal antibodies
11/23/1991CA2042973A1 Tgf-beta compositions
11/22/1991CA2042635A1 Fatty acid-pulmonary surfactant conjugates
1 ... 2991 2992 2993 2994 2995 2996 2997 2998 2999 3000 3001 3002 3003 3004 3005 3006 3007 3008 3009 3010 3011 ... 3163